Evidence-Based Guidelines for EMS Administration of Naloxone

References

• National Institute on Drug Abuse. Overdose death rates [about 7 screens]. Rockville (MD): National Institute on Drug Abuse; 2018 August [cited 2018 Sep 26]. [Internet]. https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates
   Google Scholar
• Seth P, Scholl L, Rudd RA, Bacon S. Overdose deaths involving opioids, cocaine, and psychostimulants–United States, 2015-2016. MMWR Morb Mortal Wkly Rep. 2018;67:349–58. doi:10.15585/mmwr.mm6712a1.
   PubMed Web of Science ®Google Scholar
• National Safety Council. NSC motor vehicle fatality estimates [second page]. Itasca (IL): National Safety Council; 2017 Dec [cited 2018 Sep 26]. [Internet]. https://www.nsc.org/Portals/0/Documents/NewsDocuments/2018/December_2017.pdf
   Google Scholar
• World Health Organization. Community management of opioid overdose [page 2]. Geneva, Switzerland: World Health Organization; 2014 [cited 2018 Sep 26]. [Internet]. http://www.who.int/substance_abuse/publications/management_opioid_overdose/en/
   Google Scholar
• United States Office of the Surgeon General. Surgeon general’s advisory on naloxone and opioid overdose [about 3 screens]. Washington (DC): Surgeon General; 2018 Apr 5 [cited 2018 Sep 26]. [Internet]. https://www.surgeongeneral.gov/priorities/opioid-overdose-prevention/naloxone-advisory.html
   Google Scholar
• Park TW, Lin LA, Hosanagar A, Kogowski A, Paige K, Bohnert A. Understanding risk factors for opioid overdose in clinical populations to inform treatment and policy. J Addict Med. 2016;10(6):369–81. doi:10.1097/ADM.0000000000000245.
   PubMed Web of Science ®Google Scholar
• Mueller S, Walley A, Calcaterra S, Glanz J, Binswanger I. A review of opioid overdose prevention and naloxone prescribing: implications for translating community programming into clinical practice. Subst Abus. 2015;36(2):240–53. doi:10.1080/08897077.2015.1010032.
   PubMed Web of Science ®Google Scholar
• Cash RE, Kinsman J, Crowe RP, Rivard MK, Faul M, Panchal AR. Naloxone administration frequency during emergency medical service events–United States, 2012–2016. MMWR Morb Mortal Wkly Rep. 2018;67(31):850–3. doi:10.15585/mmwr.mm6731a2.
   PubMed Web of Science ®Google Scholar
• Gulec N, Lahey J, Suozzi J, Sholl M, MacLean C, Wolfson D. Basic and advanced EMS providers are equally effective in naloxone administration for opioid overdose in Northern New England. Prehosp Emerg Care. 2018;22(2):163–9. doi:10.1080/10903127.2017.1371262.
   PubMed Web of Science ®Google Scholar
• Chou R, Korthuis PT, McCarty D, Coffin P, Griffin J, Davis-O’Reilly C, Grusing S, Daya M. Management of suspected opioid overdose with naloxone by emergency medical services personnel [Internet]. Comparative Effectiveness Review No. 193. (Prepared by the Pacific Northwest Evidence-based Practice Center under Contract No. 290-2015-00009-I.) AHRQ Publication No. 17(18)-EHC025-EF. Rockville (MD): Agency for Healthcare Research and Quality; 2017 November. www.effectivehealthcare.ahrq.gov/reports/final.cfm. doi:10.23970/AHRQEPCCER193.
   Google Scholar
• Department of Transportation, National Highway Traffic Safety Administration. National training course, emergency medical technician, paramedic, instructor’s lesson plans, Vol. 16. Washington, DC: US Government Printing Office Stock No. 050-003-00279-8; 1977 [cited 2018 Nov 15]. https://babel.hathitrust.org/cgi/pt/id=mdp.39015011479147;view=1up;seq=1
   Google Scholar
• American Chemical Society. Molecule of the Week: naloxone [about 2 screens]. Washington (DC): American Chemical Society; 2016 May 23 [cited 2018 Sep 26]. [Internet]. https://www.acs.org/content/acs/en/molecule-of-the-week/archive/n/naloxone.html
   Google Scholar
• Ryan SA, Dunne RB. Pharmacokinetic properties of intranasal and injectable formulations of naloxone for community use: a systematic review. Pain Manag. 2018;8(3):231–45. doi:10.2217/pmt-2017-0060.
   PubMed Web of Science ®Google Scholar
• McDonald R, Lorch U, Woodward J, Bosse B, Dooner H, Mundin G, Smith K, Strang J. Pharmacokinetics of concentrated naloxone nasal spray for opioid overdose reversal: phase I healthy volunteer study. Addiction. 2018;113(3):484–93. doi:10.1111/add.14033.
   PubMed Web of Science ®Google Scholar
• Rzasa LR, Galinkin JL. Naloxone dosage for opioid reversal: current evidence and clinical implications. Ther Adv Drug Saf. 2017;9(1):63–88. doi:10.1177/2042098617744161.
   PubMed Web of Science ®Google Scholar
• Kim HK, Nelson LS. Reducing the harm of opioid overdose with the safe use of naloxone: a pharmacologic review. Expert Opin Drug Saf. 2015;14(7):1137–46. doi:10.1517/14740338.2015.1037274.
   PubMed Web of Science ®Google Scholar
• American College of Medical Toxicology. ACMT and AACT position statement: preventing occupational fentanyl and fentanyl analog exposure to emergency responders [about 2 screens]. Phoenix (AZ): American College of Medical Toxicology; 2017 Jul 12 [cited 2018 Sep 26]. [Internet]. https://www.acmt.net/cgi/page.cgi/_zine.html/The_ACMT_Connection/ACMT_Statement_on_Fentanyl_Exposure
   Google Scholar
• Institute of Medicine. Clinical practice guidelines we can trust. Washington (DC): The National Academies Press; 2011. 290 p. doi:10.17226/13058.
   Google Scholar
• EMS.gov. National EMS Advisory Council (NEMSAC). Washington (DC): NHTSA Office of EMS; 2017 [cited 2018 Sep 26]. [Internet]. https://www.ems.gov/nemsac.html
   Google Scholar
• The GRADE Working Group. What is GRADE? [about 1 screen]. The GRADE Working Group; 2004-2018 [cited 2018 Sep 26]. [Internet]. http://www.gradeworkinggroup.org/
   Google Scholar
• Lang ES, Spaite DW, Oliver ZJ, Gotschall CS, Swor RA, Dawson DE, Hunt RC. A national model for developing, implementing, and evaluating evidence-based guidelines for prehospital care. Acad Emerg Med. 2012;19(2):201–9. doi:10.1111/j.1553-2712.2011.01281.x.
   PubMed Web of Science ®Google Scholar
• GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. McMaster University (developed by Evidence Prime, Inc.); 2015 [cited 2018 Sep 26]. https://gradepro.org
   Google Scholar
• Schünemann H, Brożek J, Guyatt G, Oxman A, editors. GRADE handbook for grading quality of evidence and strength of recommendations [Internet]. The GRADE Working Group; 2013 Oct [cited 2018 Sep 26]. https://gdt.gradepro.org/app/handbook/handbook.html
   Google Scholar
• Kelly AM, Kerr D, Dietze P, Patrick I, Walker T, Koutsogiannis Z. Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose. Med J Australia. 2005;182(1):24–7. Epub: 2005 January 3 [cited 2018 Oct 30]. https://www.mja.com.au/journal/2005/182/1/randomised-trial-intranasal-versus-intramuscular-naloxone-prehospital-treatment
   PubMed Web of Science ®Google Scholar
• DailyMed. Product Information: NALOXONE HCl intravenous, intramuscular, subcutaneous injection (Mylan Institutional LLC) [about 2 screens]. U.S. National Library of Medicine; 2018 Jan 17 [cited 2018 Sep 26]. [Internet]. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm/setid=d96ebf2e-1051-4b5b-b1c6-2543dbbb2d04
   Google Scholar
• Lexicomp Online. Pediatric and Neonatal Lexi-Drugs Online. Hudson (OH): Wolters Kluwer Clinical Drug Information, Inc.; 2019.
   Google Scholar
• Kleinman ME, Chameides L, Schexnayder SM, Samson RA, Hazinski MF, Atkins DL, Berg MD, de Caen AR, Fink EL, Freid EB, et al. Pediatric advanced life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Pediatrics. 2010;126(5):e1361–99.
   PubMed Web of Science ®Google Scholar
• Hegenbarth MA; American Academy of Pediatrics Committee on Drugs. Preparing for pediatric emergencies: drugs to consider. Pediatrics. 2008;121(2):433–43. <https://www.ncbi.nlm.nih.gov/pubmed/18245435>. doi:10.1542/peds.2007-3284.
   PubMed Web of Science ®Google Scholar
• Barton ED, Colwell CB, Wolfe T, Fosnocht D, Gravitz C, Bryan T, Dunn W, Benson J, Bailey J. Efficacy of intranasal naloxone as a needleless alternative for treatment of opioid overdose in the prehospital setting. J Emerg Med. 2005;29(3):265–71. <https://www.ncbi.nlm.nih.gov/pubmed/16183444>.
   PubMed Web of Science ®Google Scholar
• Vanden Hoek TL, Morrison LJ, Shuster M, Donnino M, Sinz E, Lavonas EJ, Jeejeebhoy FM, Gabrielli A. Part 12: cardiac arrest in special situations: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010;122(18 Suppl 3):S829–S61. http://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.110.971069. doi:10.1161/CIRCULATIONAHA.110.971069.
   PubMed Web of Science ®Google Scholar
• Lavonas EJ, Drennan IR, Gabrielli A, Heffner AC, Hoyte CO, Orkin AM, Sawyer KN, Donnino MW. Part 10: special circumstances of resuscitation: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2015;132(18 Suppl 2):S501–S18. https://www.ahajournals.org/doi/abs/10.1161/CIR.0000000000000264. doi:10.1161/CIR.0000000000000264.
   PubMed Web of Science ®Google Scholar
• DailyMed. Product Information: NARCAN(R) nasal spray, naloxone HCl nasal spray (Adapt Pharma, Inc) [about 2 screens]. U.S. National Library of Medicine; 2018 Jul 20 [cited 2018 Sep 26]. [Internet]. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm/setid=724df050-5332-4d0a-9a5f-17bf08a547e1
   Google Scholar
• Levine M, Sanko S, Eckstein M. Assessing the risk of prehospital administration of naloxone with subsequent refusal of care. Prehosp Emerg Care. 2016;20(5):566–9. doi:10.3109/10903127.2016.1142626.
   PubMed Web of Science ®Google Scholar
• O’Donnell JK, Halpin J, Mattson CL, Goldberger BA, Gladden RM. Deaths involving fentanyl, fentanyl analogs, and U-47700–10 States, July-December 2016. MMWR Morb Mortal Wkly Rep. 2017;66(43):1197–202. doi:10.15585/mmwr.mm6643e1.
   PubMed Web of Science ®Google Scholar